83 FR 227 pgs. 60427-60428 - Notice of Closed Meeting

Next Article Next

Type: NOTICEVolume: 83Number: 227Pages: 60427 - 60428

FR document: [FR Doc. 2018-25589 Filed 11-23-18; 8:45 am]

Agency: Health and Human Services Department

Sub Agency: Centers for Disease Control and Prevention

Official PDF Version: PDF Version

Pages: 60427, 60428

[top]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Chief Operating Officer, CDC, pursuant to Public Law 92-463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-19-001, Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among Native Americans/Alaskan Natives; RFA-IP-19-002, Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Practices in Large Health Systems through Quality Improvement Interventions; and RFA-IP-19-003, Understanding and Improving Immunization Services Among Adult Hospital Inpatient and Observation/Clinical Decision Unit Settings.

Date: March 19-20, 2019.

Time: 10:00 a.m.-5:00 p.m., (EST).

Place: Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329.

Agenda: To review and evaluate grant applications.

For Further Information Contact: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE, Mailstop E60, Atlanta, Georgia 30329, (404) 718-8833, gca5@cdc.gov.

[top] The Chief Operating Officer, Centers for Disease Control and Prevention, has

been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,

Chief Operating Officer, Centers for Disease Control and Prevention.

[FR Doc. 2018-25589 Filed 11-23-18; 8:45 am]

BILLING CODE 4163-18-P